Catch up on our picks of the latest peer-reviewed content from August 2024 across the spectrum of #RWE and #HTA. This month, featuring:
- The maze of real-world evidence frameworks: from a desert to a jungle! An environmental scan and comparison across regulatory and health technology assessment agencies. Grammati Sarri & Luis Hernandez.
- Contemporary practice and considerations for real-world data source identification and feasibility assessment. Dony Patel, Sonia G., Lina Titievsky, Susanna Flaherty, Nicholas Everage, PhD, Marta Korjagina (IQVIA), Sheuli Porkess, Tzuyung Douglas Kou, PhD, MPH, MA. & Deborah Layton.
- Real-world evidence to support regulatory submissions: A landscape review and assessment of use cases. Golnoosh Alipour-Haris, Olivia (Xinyue) L., Virginia Acha, Almut Winterstein & Mehmet Burcu.
- Leveraging real-world data in safety signal assessment. Vaishali Patadia, Katrin Manlik, Geoffrey Gipson, Jenna Willis, Ruth Namuyinga, Rachel McDermott, Anita Shaw, Mary Miller, Julius Asubonteng, Negar Golchin & Stephanie von Klot
- Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases. Justin Timbie, Alice Kim, Lawrence Baker, Rosemary Li & Thomas Concannon
- Linking clinical trial participants to their U.S. real-world data through tokenization: A practical guide. Michael Eckrote, Carrie M. Nielson, Mike L., Tyler Alexander, Rikisha G., Kim Wah Low, Zhiwei Zhang, PhD, FASA, Austin Eliazar, Reyna Klesh, Andrew Kress, Matt Bryant, Alex Asiimwe, Nicolle M Gatto & Nancy A. Dreyer
- Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe. Rosa Gini, Romin Pajouheshnia, Lia Gutierrez Cornejo et al.
- Integrating price benchmarks and comparative clinical effectiveness to inform the Medicare Drug Price Negotiation Program. Sean Sullivan, Olivier Wouters, Emma Cousin, Ayuri Kirihennedige & Inmaculada (Inma) Hernandez
Read at The Evidence Base®
#heor #healtheconomics #outcomesresearch #rwe #rwd #realworldevidence #realworlddata #marketaccess #pharma #biopharma #medicalaffairs #regulation #regulatoryaffairs #hta #healthtechnologyassessment #healthdata #healthequity #healthpolicy